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Abstract
Background: Spinal muscular atrophy is caused by reduced levels of the survival of motor neurons
(SMN) protein. SMN is found in large complexes with Sm proteins and at least eight other proteins,
including seven "gemins". These complexes are involved in the assembly of snRNPs in the cytoplasm
and their transport into the nucleus, but the precise roles of the individual protein components are
largely unknown.
Results: We have investigated the subcellular distribution of gemins using novel antibodies against
gemins 3–7, and existing mAbs against SMN, gemin2, unrip, fibrillarin and profilin II. Most gemins
were equally distributed between nuclear and cytoplasmic fractions of HeLa cells, but gemin5 and
unrip were more abundant in the cytoplasm. In a cytoplasmic extract obtained by mild disruption
of HeLa cells, nearly all the SMN and gemins 2–4 were in large complexes, but most of the gemin5
sedimented separately with a lower S value. Most of the unrip sedimented with gemins 6 and 7 near
the top of the sucrose density gradients, separate from both SMN and gemin5. Anti-SMN mAbs
pulled down gemin5 from cytoplasmic extracts, but not from nuclear extracts, and gemin5 did not
co-sediment with large SMN complexes in nuclear extracts. These data suggest that gemin5 is easily
detached from SMN-gemin complexes in the nucleus. By immuno-histochemistry, gemin5 was
rarely detectable in nuclear gems/Cajal bodies, although it was accessible to antibody and easily
detectable when present. This suggests that gemin5 is normally absent from SMN complexes in
these nuclear storage sites.
Conclusion: We conclude that SMN complexes usually exist without gemin5 in nuclear gems/
Cajal bodies. Gemin5 is believed to be involved in capturing snRNA into SMN complexes in the
cytoplasm for transport into the nucleus. We hypothesize that gemin5, though present in the
nucleus, is no longer needed for SMN complex function during the time these complexes are
stored in gems/Cajal bodies.
Background
The SMN protein forms a stable complex with a group of
proteins named gemins [reviewed in [1,2]]. The gemins
colocalize with SMN in gems/Cajal bodies (CBs) and are
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also present throughout the cytoplasm and in the nucleo-
plasm [1], although gemin4 has also been reported in the
nucleolus [3]. An early view of the structure of the SMN
complex was that gemins 2, 3, 5 and 7 bind directly to
SMN, while gemins 4 and 6 associated by interaction with
gemins 3 and 7, respectively [4]. It was later shown that a
novel protein, gemin8, mediates the binding to SMN of
the subcomplex of gemins 6 and 7 and a protein called
unrip [5]. A recent study suggests that SMN interacts
directly only with gemins 2, 3 and 8, while the subcom-
plex of gemin7 with gemin6 binds through gemin8, unrip
binds through gemin7, gemin5 binds through gemin2,
and gemin4 binds to both gemins 3 and 8 [2]. SMN com-
plexes clearly have an important and well-documented
role in both assembly of cytoplasmic snRNPs and their
transport to the nucleus [5-8]. However, a significant
amount of SMN is also found in the cytoplasm of motor
neuron axons, suggesting that SMN may have motor neu-
ron-specific functions independent of snRNP assembly
[9-17].
Immunopurification of a 300-kDa SMN-gemin2 complex
showed that it also contained spliceosomal snRNP core
proteins B/B', D1, D2, D3, E, F and G [6]. There is some
controversy in the literature on whether there is an SMN
interaction site for Sm core proteins near the C-terminus
(residues 240–267; [6]) or at residues 120–160 in the
exon3-encoded tudor domain [18]. Charroux et al [3]
described an 800 kDa complex that included SMN,
gemin2 and gemins 3 and 4. Gemins 3 and 4 were also
found without SMN in a separate 15S complex that con-
tains eukaryotic initiation factor 2C and numerous micro-
RNAs [19]. Meister et al [20] isolated two distinct SMN
complexes from HeLa nuclei, NSC1 and NSC2, that
migrated in sucrose gradients at 20S and 18S respectively.
NSC1 was U snRNA-free, but contained at least 10 pro-
teins, including SMN, gemin2, gemins 3 and 4 and Sm
proteins D1, D2 and F. They later described a complex in
both nucleus and cytoplasm that contains all gemins and
Sm core proteins, plus unrip and hsc70 [21]. Unrip is an
interacting partner of unr, a cytoplasmic RNA binding
protein involved in the translation of viral RNAs [22].
The functions of individual proteins in SMN complexes
and how they contribute to the overall function of the
complex remains unclear. A role for gemin2 in the oli-
gomerization of the SMN complex was recently shown
[24]. Gemin3 is a 103 kDa RNA helicase that binds to
Epstein-Barr virus-encoded nuclear antigens [25]. Its
binding partner, gemin4, binds to protein phosphatase 4,
overexpression of which can affect the localization of
newly formed snRNPs in HeLa cells [26] and SMN phos-
phorylation is important for U snRNP assembly [27].
Gemin4 was also found to interact with galectins 1 and 3,
which are involved in mRNA splicing [28]. Gemin5 has
thirteen WD domains which, in other proteins, form "pro-
peller" structures involved in protein-protein interactions
[29]. Gemins 6 and 7 fold together to form a structure that
resembles Sm core protein dimers [30]. It has been sug-
gested that gemin6 and gemin7 play a role in organizing
Sm proteins for assembly onto snRNAs by serving as an
Sm-like dimer surrogate around which individual Sm pro-
teins are arranged for binding to the Sm site [30]. The
gemin 6–7–8-unrip subcomplex is required for recruiting
Sm core proteins to SMN complexes [5].
We have produced novel panels of antibodies against
gemins and used them to investigate the subcellular and
molecular distribution of gemins in the cell. The studies
have revealed a striking deficiency of gemin5 in nuclear
gems/CBs and have shown that a large proportion of
gemin5 exists separately from SMN complexes.
Results
Characterization of antibodies
For this study, we produced new panels of monoclonal
antibodies (mAbs) against gemins 4, 5, 6 and 7 (Table 1).
We also produced a new polyclonal antibody against
gemin3 to complement mAbs against SMN and gemin2
described previously [31]. Our first step was to demon-
strate the specificity of the new antibodies by western
blots of total HeLa cell proteins (Fig. 1). The anti-gemin3
serum gave a single band close to the expected size of 102
kD; the GEM4D mAb against gemin4 (97 kD) is shown
alongside for comparison. Three gemin4 mAbs (GEM4B,
D and E) recognise a single band, apart from non-specific
bands caused by the secondary antibodies, but the other
three mAbs stain extra bands of higher Mr. The more spe-
cific mAbs were used in subsequent studies. All the
gemin5 mAbs stained a band consistent with the pre-
dicted Mr of 167 kD. Only the C-terminal gemin5 mAbs
(GEM5M-R) also stained a ladder of lower Mr bands
down to about 60 kD; this may be due to partial degrada-
tion of gemin5 in its N-terminal "WD-propeller" region.
The N-terminal mAbs (GEM5A-L) were not useful for
immunolocalization because they appear to recognize
only denatured and unfolded protein on western blots
(Table 1). In support of this, we were able to map the
epitope for GEM5J to amino-acids 66–71 (RVSGFT) using
phage-displayed peptide libraries as described previously
[32] and this sequence is part of the highly-structured
"WD-propeller" in the native state. Gemin6 mAbs stained
a protein of 16 kD and gemin7 mAbs a protein of 15 kD,
both migrating slightly faster than predicted by their
amino-acid sequence. Two of the gemin6 mAbs cross-
reacted with higher Mr proteins, notably one of about 32
kD. The more specific GEM6F was used in subsequent
studies. We also used antibodies against other proteins
known to interact with SMN including fibrillarin [33],
unrip and profilin II [17].BMC Cell Biology 2007, 8:28 http://www.biomedcentral.com/1471-2121/8/28
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By immunolocalization, gemin5 is absent from nuclear 
gems/Cajal bodies in most cells
We next needed to confirm that all the gemin antibodies
stained gems or Cajal bodies (gems/CBs), as previously
reported, and we found that most gemins colocalize with
SMN in nuclear gems/CBs in HeLa cells, the exception
being gemin5 (Fig. 2). Although colocalization of SMN
and gemin5 was observed in some cells (white arrows),
gemin5 was absent from gems/CBs in other cells in the
same field of view (green arrows). Gems/CBs also lacked
gemin5 in human Ntera-2 cells and skin fibroblasts. This
was the first indication that gemin5 may not always be
associated with SMN. Although gemin5 mAb does not
stain any SMN-positive gems/CBs in most nuclei, it stains
the normal number of gems in the rare gemin5-positive
nuclei. This "all or nothing" staining of gemin5 is illus-
trated in Table 2 where only positive nuclei were counted
and the average gem count was 2.41 for gemin5 compared
with 2.5–2.6 for SMN and other gemins. To determine
whether gemin5 is associating with gems or CBs in the
rare gemin5-positive nuclei, we used the HeLa PV cell line
in which gems and CBs are separate (Fig. 3A) and found
that gemin5 colocalizes with SMN in gems (Fig. 3B &3C),
but not with coilin in CBs (Fig. 3D).
Unlike other gemins, gemin5 is not co-regulated with SMN
SMN-containing gems/CBs are increased in number and
brightness in a HeLa cell line overexpressing SMN protein,
Table 1: Characterization of gemin monoclonal antibodies.
Clone Name 
mAbs
Sub class Western Blot IMF
Recom HeLa COS7 Pig Fish HeLa COS7
1A8 GEM4A IgA ++ + + ++ - n.d. n.d.
1G4 GEM4B IgG1 ++ + + ++ - ++
9E6 GEM4C IgG2b ++ + + ++ - ++
2H8 GEM4D IgG1 ++ + + ++ - ++
7B5 GEM4E IgG2a ++ + + ++ - ++
2A2 GEM4F IgG2b ++ + + ++ - ++
1A5 GEM5A IgG1 ++ ++ - - --
1B1 GEM5B IgG2a + ++++ +++ - + --
1C10 GEM5C IgG2b ++++- --
2A12 GEM5D IgG2b ++++- --
2B11 GEM5E IgG2a + ++++ ++ - + --
5C3 GEM5F IgG2a ++ + + +- - --
6C4 GEM5G IgG1 ++ + + +- + --
6E2 GEM5H IgG2b + +++ +++ - + --
7A1 GEM5I IgG1 ++ + + +- + --
7F1 GEM5J IgG1 +++- - --
8C7 GEM5K IgG2b + ++++ +++ - + --
8E7 GEM5L IgG2b ++ ++ - + --
1E12 GEM5M IgG1 + +++ ++ ++ - ++
2E6 GEM5N IgG1 + ++++ +++ ++ - ++
3E11 GEM5O IgG1 + +++ ++ ++ - ++
3G2 GEM5P IgG1 + ++++ +++ ++ - ++
4G7 GEM5Q IgG1 + +++ +++ ++ - ++
6G5 GEM5R IgG1 + ++++ +++ ++ - --
2C11 GEM6A IgG2a +++- - ++
4H6 GEM6B IgG2a ++ ++ + - ++
5E9 GEM6C IgG1 +++- - --
6F5 GEM6D IgG2a ++++- ++
8A9 GEM6E IgG2a +++- - ++
8D8 GEM6F IgG2a ++ ++ + - +-
3F12 GEM6G IgG2b +++- - +-
2A11 GEM7A IgG1 +++- - ++
6A2 GEM7B IgG1 + +++ ++ - - ++
6A9 GEM7C IgG1 ++ ++ - - --
7A12 GEM7D IgG1 ++ ++ - - ++
8D8 GEM7E IgG1 +++- - ++
8H1 GEM7F IgG1 + +++ ++ + - ++
10C12 GEM7G IgG1 +++- - ++BMC Cell Biology 2007, 8:28 http://www.biomedcentral.com/1471-2121/8/28
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Characterization of gemin antibodies by western blots of total HeLa cell proteins Figure 1
Characterization of gemin antibodies by western blots of total HeLa cell proteins. An SDS extract of HeLa cells 
was run as a horizontal strip alongside Mr markers on SDS-PAGE and transferred to nitrocellulose membranes by electroblot-
ting. 7% acrylamide was used for (a)-(c) with prestained Sigma markers and 14% for (d) and (e) with prestained SeeBlue mark-
ers. The blot was either cut into vertical lanes or, in (c) only, used directly on a 28-lane miniblotter apparatus. In each case, the 
main antigen band is shown as a broken arrow. (a) gemin3 antiserum stains a single protein of about 102 kD (97 kD gemin4 is 
shown as a marker). (b) the panel of 6 gemin4 mAbs all stain a band of 97 kD, but 3 of them (GEM4A, C and F) cross-react 
with several higher Mr proteins. Non-specific bands (*) are due to the secondary antibody system. (c) the 12 mAbs against the 
gemin5 N-terminal region stain a single band consistent with the 167 kD expected for gemin5 and the 6 mAbs against the C-
terminal region stain the same band, together with a ladder of smaller bands that may be degradation products. (d) The 7 
gemin6 mAbs all stain a band of 16 kD, but 2 of them cross-react with a 32 kD band. (e) All 7 gemin7 mAbs stain a single band 
of 15 kD.BMC Cell Biology 2007, 8:28 http://www.biomedcentral.com/1471-2121/8/28
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Gemins 3, 4, 6 and 7 colocalise with SMN in nuclear gems/CBs, but gems/CBs in most cells lack gemin5 Figure 2
Gemins 3, 4, 6 and 7 colocalise with SMN in nuclear gems/CBs, but gems/CBs in most cells lack gemin5. HeLa 
cells grown on coverslips were fixed with 1% formalin in PBS and permeabilized with 1% Triton X-100. Gemins 4, 5, 6 and 7 
were identified using GEM4E, GEM5Q, GEM6F and GEM7E, respectively in a double label with SMN rabbit antiserum. Typical 
fields are shown, except that an unusual field containing several cells with gemin5-positive gems/CBs was chosen for GEM5Q. 
The anti-gemin3 rabbit antiserum was double-labelled with MANSMA1 mAb against SMN. Alexa fluor 546 goat anti-mouse IgG 
(red) and Alexa fluor 488 goat anti-rabbit IgG (green) were used as second antibodies. DAPI (blue) was used to counterstain 
the nuclei. (See text for white and green arrows).BMC Cell Biology 2007, 8:28 http://www.biomedcentral.com/1471-2121/8/28
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so we set out to determine whether antibody staining of
these structures for gemins was also increased. Gemins 2,
3, 4, 6 and 7 did colocalize with SMN in these up-regu-
lated gems/CBs, but gemin5 was still not detected in these
structures (Fig. 4ab). Fig. 4b shows that unrip also colocal-
ises with the up-regulated gems/CBs and that traces of
fibrillarin, a predominantly nucleolar protein, can also be
detected in the up-regulated gems/CBs (at such low levels,
however, the possibility of a slight cross-reaction of this
auto-antiserum cannot be entirely ruled out). Fig. 4b also
confirms earlier evidence [31] that coilin, the marker for
Cajal bodies, is up-regulated in gems/CBs when SMN lev-
els are increased by transfection.
SMN on western blots was decreased to 30–40% of con-
trol levels in cultured skin fibroblasts derived from an
SMA type I patient (Fig. 5). Most gemins were also
decreased by a similar proportion, but gemin5 showed a
Table 2: Gemin5 staining is "all or nothing".
mAb Number of nuclei with gems/CBs Total number of gems/CBs Average number of gems/CBs per 
positive nucleus
MANSMA1 113 290 2.57
MANSIP1A 93 242 2.60
GEM4E 103 257 2.50
GEM5Q 27 65 2.41
GEM6F 114 286 2.51
GEM7E 111 280 2.52
In those rare HeLa cell nuclei that have gemin5-positive gems/CBs, nearly all gems/CBs were positive for gemin5. HeLa cell cultures on glass 
coverslips were fixed with 50:50 acetone: methanol, dried and labelled individually with gemin mAbs. Only nuclei with positive gem/CB staining 
were counted.
In Hela PV cells, which have separate gems and CBs, gemin5 colocalizes with gems, not CBs, in those rare cells that do have  gemin5-positive nuclear bodies Figure 3
In Hela PV cells, which have separate gems and CBs, gemin5 colocalizes with gems, not CBs, in those rare cells 
that do have gemin5-positive nuclear bodies. HeLa strain PV cells grown on coverslips were fixed with 1% formalin in 
PBS and permeabilized with 1% Triton X-100. (A) Separation of gems (red: MANSMA1 mAb and Alexa-546 anti-mouse Ig) and 
CBs (green: rabbit anti-coilin and FITC anti-rabbit Ig) in HeLa PV, counterstained with DAPI (blue). Rare gemin5-positive 
nuclear bodies were double-labelled with (B) mAb GEM5P and Alexa-546 anti-mouse Ig and (C) rabbit anti-SMN and FITC anti-
rabbit Ig to show colocalization of SMN and gemin5 (white arrows). (D) is an overlay from a double label with GEM5P (red) 
and rabbit anti-coilin (green) with a DAPI counterstain (blue), showing no colocalization.BMC Cell Biology 2007, 8:28 http://www.biomedcentral.com/1471-2121/8/28
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Overexpression of SMN in HeLa cells stimulates formation of gems/CBs containing other gemins, except gemin 5 Figure 4
Overexpression of SMN in HeLa cells stimulates formation of gems/CBs containing other gemins, except 
gemin 5. Gemin2 (A), gemin 4 (B), gemin6 (D) and 7 (E) co-localise with SMN in HeLa cells stably transfected with human 
SMN1 in pcDNA3 [49]. Gemin5 (C) does not co-localise with SMN. The same mAbs as in Fig. 2 were used, plus MANSIP1A 
for gemin2. Double label of SMN mAb MANSMA1 with gemin3 rabbit antiserum (F), unrip rabbit antiserum (G) and fibrillarin 
human auto-antiserum (H), or SMN antiserum with p80 mAb (I) were performed on the HeLa cell line stably transfected with 
SMN1. Alexa fluor 546 goat anti-mouse IgG (red) was used to detect mouse mAbs and Alexa fluor 488 goat anti-rabbit IgG 
(green) was used to detect rabbit antibodies. FITC-conjugated goat anti-human IgG (Chemicon) was used to detect fibrillarin. 
DAPI (blue) was used to counterstain the nuclei.BMC Cell Biology 2007, 8:28 http://www.biomedcentral.com/1471-2121/8/28
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smaller reduction (Fig. 5). These reductions in SMA
fibroblasts were also evident by immunofluorescence
microscopy (Fig. 6). SMN and most gemins showed dras-
tically decreased levels in both nuclear gems and cyto-
plasm in SMA fibroblasts. Gemin5, however, remained
stable in the cytoplasm, consistent with the western blot
data in Fig. 5 and with the existence of a separate pool of
gemin5, independent of SMN.
Unlike other gemins, gemin5 is present mainly in the 
cytoplasm
We next examined the distribution of SMN and gemins
between nucleus and cytoplasm using a simple cell frac-
tionation followed by western blotting (Fig. 7). To mini-
mise quantitation problems with X-ray film exposure, we
used 100%, 50% and 25% dilutions of each extract and
compared the closest match by microdensitometry. Com-
parisons can only be reliably made between fractions of
the same protein, and not between different proteins,
because of possible differences in antibody avidity. In
HeLa cells, SMN and most gemins were equally distrib-
uted between nucleus and cytoplasm, but gemin5 was
predominantly cytoplasmic. This could mean that gemin5
has additional SMN-independent functions in the cyto-
plasm, but it is also possible that gemin5 is turned over in,
or exported from, the nucleus more quickly than other
gemins. HeLa cells are widely used for SMN studies but it
would be unwise to assume that they are representative of
human cells in general. In the neurogenic cell line, Ntera-
2, we found that SMN and gemins were much more cyto-
plasmic than in HeLa cells. In both skin fibroblasts and
Ntera-2 cells, gems/CBs were rarely, if ever, stained by
anti-gemin5 mAbs (data not shown).
On sucrose density gradient analysis, gemin5 is absent 
from SMN complexes in nuclear extracts, but not in 
cytoplasmic extracts
The extent to which gemin5 and other gemins are present
in complexes with SMN was studied by sucrose density
gradient centrifugation. We analysed a total extract of
HeLa cells prepared using a RIPA buffer and an extract sep-
arated into nuclear and cytoplasmic fractions using the
established method of Meister et al [20]. These experi-
ments were repeated three times starting with fresh HeLa
cells and a representative result is shown in Fig. 8. It seems
likely that some detachment of proteins from the SMN
complexes occurs during cell lysis or fractionation with
the harsher RIPA or high-salt nuclear buffers. Thus, no
SMN or gemin2 is seen at the top of the gradient in low-
salt cytoplasmic extracts (Fig. 8b) but they are present
when RIPA buffer (Fig. 8a) or higher salt (Fig. 8c) are used.
The mild extraction used for the cytoplasmic fraction is
more likely to yield intact SMN complexes (Fig. 8b) but,
although most of the SMN and gemins 2, 3 and 4 sedi-
mented in large complexes, the majority of both gemin5
and unrip remained in the upper part of the gradient
(<19S), together with a significant proportion of
gemins6/7. This would be consistent with these latter pro-
teins having some additional functions outside SMN
complexes.
Successful subcellular fractionation is shown by the pres-
ence of nuclear markers, such as lamin A/C, emerin, coilin
p80 and fibrillarin, only in the nuclear fraction while pro-
filin II was present only in the cytoplasmic fraction. As
expected, all gemins and unrip are partly present in large
complexes migrating near the bottom of the sucrose gra-
dient, whereas other nuclear protein markers, emerin and
lamin A/C, remained in the upper half of the gradient.
Fibrillarin is clearly sedimenting in high molecular weight
complexes but since most fibrillarin is in the nucleolus
and very little colocalizes with SMN, this material seems
unlikely to represent complexes with SMN. SMN, how-
ever, does colocalize with fibrillarin in the nucleolus in
fetal tissues [34] and the possibility that SMN is com-
plexed with fibrillarin in a "masked" form [35] in HeLa
nuclei has never been ruled out. The proteins in the upper
half of the gradients would be consistent in size with
monomers or small homo- or hetero-oligomers. Thus,
gemins 6 and 7 (15–19 kD) are in the first two fractions,
while SMN and gemin2 (32–38 kD) co-sediment close to
the 7S marker. Gemin5 (167 kD) monomers would be
expected around 7S and its faster sedimentation at around
11S might be consistent with a proposed trimeric struc-
ture [29].
Gemin5 did not co-sediment at all with the large SMN
complexes in the nuclear extract (Fig. 8c), consistent with
its absence from gems/CBs (Fig. 2). However, the possibil-
ity that gemin5 detached from the complexes during frac-
tionation cannot be ruled out. In a recent study, gemin5
was more easily detached by high salt than other gemins
[2], though this occurred at higher salt concentrations
(>500 mM) than those used for nuclear extraction (440
mM total). Adding extra KCl to cytoplasmic extracts to
440 mM did not dissociate gemin5 from SMN (see Fig. 9b
below), but the possibility that nuclear complexes are less
stable cannot be ruled out. Therefore, we have restricted
our major conclusions to the clear invivo reduction of
gemin5 in nuclear gems/CBs by immunolocalization
studies (Fig. 2), which cannot be explained by fractiona-
tion artefacts, and to the complexes present under mild
extraction conditions (Fig. 8b).
Gemins co-sedimenting on sucrose gradients form true 
complexes in which all gemins are accessible to antibody
Immunoprecipitation experiments were performed to
demonstrate true complex formation, as opposed to co-
sedimentation on the sucrose gradients. MANSMA1 anti-
SMN mAb pulled down gemin5 from cytoplasmic com-BMC Cell Biology 2007, 8:28 http://www.biomedcentral.com/1471-2121/8/28
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plexes only, in agreement with sucrose gradient data (Fig.
8), whereas it pulled down SMN itself and the gemin4
control from both nuclear and cytoplasmic complexes
(Fig. 9a). To determine whether the absence of gemin5
from SMN complexes in nuclear extracts was due to dis-
ruption by high salt, cytoplasmic extracts were studied
after adding KCl to the same concn as the nuclear extracts
and gemin5 was still pulled down by the anti-SMN mAb
(Fig. 9b). To show that all gemins are accessible to anti-
body in SMN complexes, the immunoprecipitation exper-
iment was reversed and various anti-gemin mAbs were
used to pull-down endogenous SMN protein from a total
HeLa extract in RIPA buffer. This extract contains both
nuclear and cytoplasmic complexes, and all gemin mAbs,
including gemin5, pulled down SMN (Fig. 9c). The pre-
dictable exception was a mAb that only recognizes dena-
tured gemin5 on blots and would not be expected to bind
native complexes. This experiment confirms that gemin5
in SMN complexes is as accessible to antibody as the other
gemins and shows that masking of gemin5 epitopes can-
not explain the absence of gem/CB staining by gemin5
mAbs in immunofluorescence microscopy (Fig. 2).
Discussion and conclusion
The idea that SMN complexes may vary in composition is
not a novel one. Dreyfuss and co-workers have explained
their own data in terms of a range of structures from SMN-
gemin2 heterodimers upwards [36]. It is also implicit in
the studies of Meister et al [20,21]. The possibility that
compositional changes may be relevant to understanding
the function of SMN complexes has not, however, been
fully explored, partly because the roles of the SMN com-
plex and its individual protein components are still not
fully understood and partly because of the uncertainty
about the stability of complexes after cell disruption for
biochemical studies.
In the present study, sucrose gradient analysis has shown
that SMN complexes in nuclear extracts have little or no
gemin5. This was also noted in an earlier study [27]. Pull-
down experiments with anti-SMN mAb confirmed that
SMN is associated with gemin5 in cytoplasmic extracts but
not in nuclear extracts. A major problem with subcellular
fractionation, however, is the difficulty in ruling out pos-
sible dissociation during biochemical fractionation, with
some components of SMN complexes being more easily
dissociated than others. In our hands, raising the salt
concn in cytoplasmic extracts to 440 mM (same as nuclear
extracts) did not noticeably dissociate gemin5 from SMN
and this agrees with a recent study showing that a higher
concentration (>500 mM) is required to do this [2]. Even
so, we cannot rule out the possibility that some dissocia-
tion of SMN complexes has occurred in nuclear extracts.
Therefore, the observation in intact cells that gemin5 does
not colocalize with SMN and all other gemins in nuclear
gems/CBs is important to show that its absence from com-
plexes is not just an artefact of biochemical fractionation.
It is significant that gemin5 was found in gems/CBs in a
very small proportion of HeLa cells (<1%) and that, when
present, it was present in all gems/CBs of that nucleus.
This is a key observation since it shows that gemin5 is eas-
ily detected by immunofluorescence microscopy, when it
is present. It also suggests that these minority cells may
differ metabolically or phenotypically from the majority.
The possibility that binding of mAbs to gemin5 was
masked by other components of the SMN complex is
All gemins, except gemin5, are proportionately reduced in  SMN-deficient human skin fibroblasts Figure 5
All gemins, except gemin5, are proportionately 
reduced in SMN-deficient human skin fibroblasts. 
Total SDS extracts of the two skin fibroblast cell lines (Cori-
ell cell lines, GM08333, control and GM03813, SMA) were 
subjected to SDS-PAGE on adjacent lanes of a 7% or 14% 
acrylamide gel (cf. Fig. 1), followed by western blotting with 
the same antibodies used in Fig. 2 plus MANSIP1A for 
gemin2. β-actin was used as a control for equal loading of the 
gel lanes. Microdensitometry was used to express protein 
levels in SMA fibroblasts as a percentage of those in control 
fibroblasts.BMC Cell Biology 2007, 8:28 http://www.biomedcentral.com/1471-2121/8/28
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Nuclear gems/CBs and cytoplasmic levels of most gemins are greatly reduced in SMN-deficient human skin fibroblasts, but  cytoplasmic gemin5 levels remain high Figure 6
Nuclear gems/CBs and cytoplasmic levels of most gemins are greatly reduced in SMN-deficient human skin 
fibroblasts, but cytoplasmic gemin5 levels remain high. Alexa fluor 546 goat anti-(mouse IgG) (red) was used to detect 
SMN and gemin 2, 4, 5, 6 and 7 primary mAbs (the same mAbs as in Fig. 2). TRITC donkey anti-(rabbit Ig) was used to detect 
anti-gemin3 rabbit antibodies. DAPI (blue) was used to counterstain the nuclei.BMC Cell Biology 2007, 8:28 http://www.biomedcentral.com/1471-2121/8/28
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ruled out by the fact that the same gemin5 mAbs are as
capable of immunoprecipitating SMN as mAbs against
other gemins (Fig. 9c). Overexpression of SMN in a stably-
transfected HeLa cell line increases the number and
brightness of nuclear gems/CBs when stained with SMN
antibodies or with most other gemin antibodies, but it did
not bring about increased immunostaining of gemin5 in
gems/CBs, which we might expect if the gemin5 mAbs
were simply rather weak in immunostaining. We hypoth-
esize that the most important role of gemin5 is in the cyto-
plasmic part of the SMN cycle and that its role becomes
less important once the assembled snRNPs have been
transported to the nucleus by the SMN complex. Gubitz et
al [29] have suggested that the WD propeller structure of
the gemin5 N-terminal domain may act as an assembly
platform for other proteins and recent reports suggest that
gemin5 is involved in binding the snRNA component for
snRNP assembly [37].
It is also of interest that, even in the cytoplasm, a signifi-
cant proportion of the gemin5 is unassociated with SMN
complexes. This is evident both from the sucrose gradients
in Fig. 8b and from the fact that both cytoplasmic gemin5
staining and gemin5 levels on western blots remain strong
in type I SMA fibroblasts, when SMN and other gemins are
clearly reduced by 60–70% relative to control fibroblasts.
Similarly, RNAi knockdown of SMN had comparatively
little effect on gemin5 levels (cf. Fig. 2A of Feng et al,
[38]). Feng et al [38] also showed that RNAi knockdown
of gemin5 did not affect gems/CBs or the levels of other
SMN complex components on western blots. Similarly,
Shpargel and Matera [39] found that RNAi knockdowns
of SMN or gemins 2, 3 or 4 all disrupted Sm core protein
assembly, whereas knockdown of gemin5 had no effect.
These observations are consistent with our data, though
the presence of a larger cytoplasmic pool of "free" gemin5
could mean that a much more efficient knockdown of
Distribution of gemins and other proteins between cytoplasmic and nuclear fractions of HeLa and Ntera2 cells Figure 7
Distribution of gemins and other proteins between cytoplasmic and nuclear fractions of HeLa and Ntera2 
cells. HeLa C and Ntera C are cytoplasmic fractions, HeLa N and Ntera N are nuclear fractions. After extraction with cyto-
plasmic buffer (see Methods), the whole pellet was boiled in SDS sample buffer to obtain the "nuclear" extract. Samples were 
loaded as serial dilutions (from left to right, 1/4, 1/2 and 1) for more accurate microdensitometry quantitation. γ tubulin and 
lamin A/C were used as controls for cross-contamination between nuclear and cytoplasmic fractions.BMC Cell Biology 2007, 8:28 http://www.biomedcentral.com/1471-2121/8/28
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gemin5 would be required to obtain the same result as
other gemin knockdowns.
An excess of "free" gemin5 over that required for SMN
complexes might imply a more general role for gemin5.
An interaction with eukaryotic initiation factor 4E has
recently been described and a role for gemin5 in assembly
or processing of messenger RNP complexes was suggested
[40]. In their study, mass spectrometry did not reveal SMN
or any other gemins in these gemin5 complexes. The pos-
sibility that gemin5 may have a more general role in RNP
assembly was raised by Gubitz et al [29]. Unrip is another
WD-repeat protein, like gemin5, and it also has a clearly-
demonstrated role in mRNA translation initiation [22]. A
further role for unrip in assembling mRNA export and
transport intermediates has recently been proposed [41].
Carissimi et al [23] and Grimmler et al [42] also found
that unrip, like gemin5 in the present study, was predom-
inantly cytoplasmic and not localized in nuclear gems/
CBs. Our results confirm the mainly cytoplasmic distribu-
tion of unrip (Fig. 8), but a small amount of unrip in the
nuclear fraction was present in large complexes (Fig. 8)
and was detectable in nuclear gems/CBs of HeLa cells
overexpressing SMN (Fig. 4G). These differences between
laboratories could be due to antibody avidity or SMN
expression levels and a consensus may be that both of
these two WD-repeat proteins, gemin5 and unrip, are
present at relatively low, often undetectable, levels in
gems/CBs. It may be that both proteins are involved in
assembling complexes of SMN with RNA and other pro-
teins but are no longer essential when the complexes
arrive in nuclear gems/CBs.
Although SMN and profilin II interact in vitro and are
both detectable in nuclear gems/CBs in neuronal cells
[17], we found no evidence for the presence of profilin II
in the SMN-containing complexes (Fig. 8), possibly
because the interaction is weaker and profilin I may be the
dominant isoform in HeLa cells. Coilin was not found in
the large SMN complexes, although a methylated form
can interact with SMN [43] and it does colocalize with
nuclear SMN in gems/Cajal bodies in most HeLa cell
lines. However, SMN and coilin p80 can also form quite
separate gems and Cajal bodies in fetal tissues [34] and
coilin p80 is exclusively nuclear, so the result is not alto-
gether surprising. SMN complexes involve so many pro-
teins, even the "core" complex let alone ancillary
interactors, that much work remains to be done in eluci-
dating what exactly is binding to what under different cel-
lular conditions [1,2]. There is evidence, for example, that
Distribution of SMN and gemins between large, fast-sedimenting SMN complexes and slower sedimenting fractions Figure 8
Distribution of SMN and gemins between large, fast-sedimenting SMN complexes and slower sedimenting 
fractions. HeLa total, cytoplasmic and nuclear extracts were prepared and analyzed by centrifugation on 15–30% sucrose den-
sity gradients. Thirty 1 ml fractions were collected from each gradient and the protein contents were concentrated into 0.1 ml 
using Strataclean resin. Every other fraction (1, 3, 5, etc) was subjected to SDS-PAGE for western blotting using appropriate 
antibodies. The size markers were immunoglobulin (7S), catalase (11S) and thyroglobulin (19S).BMC Cell Biology 2007, 8:28 http://www.biomedcentral.com/1471-2121/8/28
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(A) Co-immunoprecipitation with MANSMA1 anti-SMN mAb shows that SMN and gemin5 exist as complexes in cytoplasmic  extracts, but not in nuclear extracts (arrows show lanes to be compared) Figure 9
(A) Co-immunoprecipitation with MANSMA1 anti-SMN mAb shows that SMN and gemin5 exist as complexes in cytoplasmic 
extracts, but not in nuclear extracts (arrows show lanes to be compared). SMN and gemin4 controls are pulled down from 
both extracts equally. (B) Addition of KCl to the cytoplasmic extract to the same concentration as nuclear extraction buffer 
did not disrupt the SMN-gemin5 interaction. (C) All gemins in SMN complexes were accessible to appropriate antibodies. All 
anti-gemin antibodies pulled down SMN from total RIPA extracts of HeLa cells, except GEM5G which only recognizes dena-
tured gemin5 on western blots (this also acts as a negative control). Antibodies were (left to right; see Table 1): No mAb (input 
control), GEM6B, GEM7B, GEM5G, GEM5P, GEM4C, GEM4D, MANSIP1B, MANSIP1A, rabbit anti-gemin3 and MANSMA1. In 
each case, 0.05 ml of Dynabead magnetic beads (Dynal, Oslo, Cat. No. 100.41), with anti-mouse Ig (or anti-rabbit Ig) attached 
covalently, were incubated with 0.1 ml of undiluted mAb culture supernatant (or 1/100 dilution antiserum) for 1 h at 4°C, 
washed 3× with PBS containing 0.1% BSA, and then incubated for 16 h at 4°C with 0.08 ml of HeLa extract (also sampled as 
"input"). After removing the "unbound" extract, the beads were washed 5× with PBS and boiled in 0.02 ml of SDS sample 
buffer. Gels (10% or 12.5% polyacrylamide) were loaded with 0.01 ml of SDS extract for SDS-PAGE and western blotting with 
anti-SMN mAb MANSMA12, as described in Methods. All lanes loaded with SDS extracts of beads contain a 50 KDa band of 
mouse Ig heavy chain which reacts with the HRP anti-mouse Ig used to develop the blot (band is absent from input and when 
rabbit antisera are used on beads).BMC Cell Biology 2007, 8:28 http://www.biomedcentral.com/1471-2121/8/28
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the activity of SMN in a snRNP assembly assay can vary
developmentally without changing SMN levels [44],
though it is not known whether this requires any changes
in SMN complex components. The present study suggests
that gemin5 works only "part-time" as a component of
SMN complexes, in the sense that they can exist without
gemin5 and that gemin5 may have functions that are
independent of SMN complexes, though possibly involv-
ing related assembly functions. In some ways, the behav-
iour of gemin5 resembles that of another WD-repeat
protein, unrip, as reported either in this study or else-
where.
Methods
Cloning and expression of gemin cDNAs
Total RNA was isolated from HeLa cells using an RNAeasy
Midi Kit (Qiagen) and converted to cDNA using Sensis-
cript reverse transcriptase (Qiagen) and random hexamer
primers. Specific gemin cDNA sequences were obtained
by PCR using the primers shown in Table 3. The primers
contained restriction sites for cloning into pET21b or
pET32b; EcoRI and XhoI for gemin4, BamHI and HindIII
for gemin5 and BamHI and XhoI for gemins 6 and 7. The
gemin3 PCR product was cloned into the pT7Blue plas-
mid, cut from it using the plasmid BamHI and XhoI sites
and subcloned into the same sites of pET21b. The cDNAs
encoded aa 18–362 of gemin3, the first 650aa of gemin4,
aa55–407 for gemin5 N-terminal region, aa 1217–1508
for gemin5 C-terminal region and full-length for gemins 6
and 7. All constructs were sequenced to check for PCR
errors. For immunogen production, gemins 3, 4 and N-
terminal gemin5 were expressed from pET21b and the rest
from pET32b.
Transformed bacteria [E. coli BL21(DE3)] were induced
with 1 mM IPTG for 3 h at 37°C. Expressed fusion protein
was purified from inclusion bodies by sequential extrac-
tion with increasing concentrations (2 M, 4 M, 6 M, 8 M)
of urea in phosphate-buffered saline (PBS). The extracts in
6 M urea were then purified by affinity chromatography
with His. Bind resin (Novagen).
Production of antibodies
Monoclonal antibodies were produced by immunization
of BALB/c mice and fusion of spleen cells with Sp2/0 mye-
loma cells as described elsewhere [45]. Both the mouse
sera and the hybridoma culture supernatants were
screened by elisa, Western blot (HeLa total protein
extract) and immunofluorescence microscopy (nuclear
gems/CBs in HeLa cells). Hybridoma cell lines were
cloned to homogeneity by limiting dilution. Ig subclass
was determined using an isotyping kit (Zymed, San Fran-
cisco). Polyclonal antibodies were produced commer-
cially by immunization of a New Zealand White rabbit
with recombinant protein (Harlan SeraLab, Loughbor-
ough, UK).
Other antibodies used in this study were rabbit antiserum
against SMN and mAbs MANSMA1 and MANSIP1A
against SMN and gemin2 [31], mAb 5P10 against coilin
p80 (gift of Angus Lamond, University of Dundee, UK
[46]), human autoantiserum against fibrillarin (gift of K.
Michael Pollard, Scripps, San Diego [33]), mAb MANEM5
against emerin [47], mAb MANLAC1 against lamin A/C
[48], mAb PF2A3 against profilin II and rabbit antiserum
against unrip [17], mAb 8226 against beta-actin and rab-
bit antiserum 11317 against gamma-tubulin (Abcam,
Cambridge, UK).
SDS-PAGE and western blotting
SDS-PAGE and western blotting were carried out as
described elsewhere [17]. Protein bands were visualized
by development with peroxidase-conjugated rabbit anti-
(mouse Ig) (DAKOpatts) and a chemiluminescent system
(SuperSignal; Pierce). Quantitation was performed by
microdensitometry of captured blot images using Laserpix
software (BioRad Laboratories). To minimize problems
with non-linear response of X-ray film, several dilutions
Table 3: Oligonucleotide primers for PCR
Primer Primer sequences (5'-3')
Gemin6F gag gat ccc atg agt gaa tgg atg aag
Gemin6R gcc tcg agt cat tgg gaa gct gta aga
Gemin7F gag gat cca atg caa act cca gtg aac
Gemin7R gcc tcg agt tat ggc ttg aag gta ta
Gemin3F agt gac cta ctg ttg ccg g
Gemin3R cat ctt cct ggg ctt cag tgc
Gemin 4F atc gcg aat tcc atg gac cta gga ccc ttg
Gemin 4R ata att ctc gag cag cac ctc gtc tgg ctc
Gemin 5FN gca ctg gat cct cga gtc ata gga gag ttg
Gemin 5RN gct cgg aag ctt cca tac acg gat cat gcc
Gemin 5FC aat tag gat ccg atg gcc tcc tgg gac gag
Gemin 5RC gcg cgg aag ctt cat aca gaa ggt ctg gcaBMC Cell Biology 2007, 8:28 http://www.biomedcentral.com/1471-2121/8/28
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of cell extracts were blotted and those that gave the same,
or similar, intensities in a linear response region were
used for comparative quantitation.
Immunohistochemistry
HeLa, Ntera-2 (NT-2) and skin fibroblast (GM08333, con-
trol and GM03813, SMA from Coriell Cell Bank, Camden,
NJ) cell lines and the stably-transfected SMN-overex-
pressor fibroblast cell line were grown on coverslips in
DMEM with 10% horse serum and fixed with 1% forma-
lin or 50:50 acetone-methanol. As shown previously [49],
the levels of recombinant SMN over-expression in the sta-
bly-transfected cell line were similar to endogenous SMN
levels, thus approximately doubling total SMN levels. For-
malin-fixed cells were permeabilized with 1% Triton X-
100 and blocked with 1% glycine before use. For double
labeling experiments, coverslips were incubated with the
mouse mAb for 1 h, followed by the rabbit polyclonal
antibody for 1 h. Alexa488- or Alexa546-conjugated goat
anti-(mouse Ig) and goat anti-(rabbit Ig) (Molecular
Probes, Eugene, OR) were then applied. Nuclei were
revealed with a DAPI counter stain and slides were viewed
using the L4 filter set and a 63× oil immersion objective
on a Leica DMRB photomicroscope. Images were captured
using an integrating camera and frame-grabber under
standard and comparable conditions.
Subcellular fractionation studies
300–600 ml of HeLa cells were grown in suspension cul-
ture for 4 days and washed in ice-cold PBS. The pellet was
resuspended in 4 volumes of RIPA buffer (1% NP40,
0.25% deoxycholate, 1 mM EDTA, 1 mM PMSF, 150 mM
NaCl, 50 mM Tris-HCl pH 7.4), left on ice for 30 minutes,
homogenizing every 10 minutes. The homogenate was
centrifuged at 13,000 g for 15 minutes at 4°C and the
supernatant retained. Cytoplasmic and nuclear fractions
were prepared as described by Meister et al [20]. Briefly,
HeLa cells were homogenized in 10 mM KCl, 10 mM
HEPES-KOH pH 7.9, 1.5 mM MgCl2, 0.5 mM PMSF and
0.5 mM dithiothreitol and centrifuged for 10 minutes at
1000 g at 4°C. The supernatant was clarified further at
13,000 g for 10 minutes at 4°C to produce the cytoplas-
mic fraction. The nuclear pellet was homogenized in 1 ml
of 420 mM KCl, 20 mM HEPES-KOH pH 7.9, 1.5 mM
MgCl2, 0.5 mM PMSF, 0.2 mM EDTA and 5% glycerol, left
for 30 minutes on ice and then centrifuged 13,000 g for 30
minutes at 4°C. The supernatant was designated as the
nuclear fraction.
RIPA extracts or cytoplasmic and nuclear fractions were
analysed on 35 ml 15–30% sucrose density gradients in
150 mM NaCl, 50 mM Tris HCl pH 7.4 and 5 mM MgCl2
by centrifugation in a Beckmann SW28 rotor at 25,000 g
for 21 hours at 4°C. Thirty fractions were collected and
every other fraction was concentrated 10-fold using Strata-
clean resin (Stratagene, Amsterdam, Netherlands) and
analyzed by SDS-PAGE and western blotting.
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